Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | cGMP-dependent 3',5'-cyclic phosphodiesterase | ||
| Ligand | BDBM50263791 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_1729499 (CHEMBL4144777) | ||
| IC50 | 0.400000±n/a nM | ||
| Citation |  Stepan, AF; Tran, TP; Helal, CJ; Brown, MS; Chang, C; O'Connor, RE; De Vivo, M; Doran, SD; Fisher, EL; Jenkinson, S; Karanian, D; Kormos, BL; Sharma, R; Walker, GS; Wright, AS; Yang, EX; Brodney, MA; Wager, TT; Verhoest, PR; Obach, RS Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189. ACS Med Chem Lett9:68-72 (2018) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| cGMP-dependent 3',5'-cyclic phosphodiesterase | |||
| Name: | cGMP-dependent 3',5'-cyclic phosphodiesterase | ||
| Synonyms: | CGS-PDE | Cyclic GMP-stimulated phosphodiesterase | Homo sapiens phosphodiesterase 2A (PDE2A) | NM_002599 | PDE2A | PDE2A_HUMAN | cGSPDE | ||
| Type: | Enzyme Catalytic Domain | ||
| Mol. Mass.: | 105691.58 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | O00408 | ||
| Residue: | 941 | ||
| Sequence: |
| ||
| BDBM50263791 | |||
| n/a | |||
| Name | BDBM50263791 | ||
| Synonyms: | CHEMBL4062397 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C19H17F3N6O2 | ||
| Mol. Mass. | 418.3725 | ||
| SMILES | Cc1nn(C)c(c1-c1nc(CO)c2n1nc(C)[nH]c2=O)-c1ccc(cc1)C(F)(F)F |(22.28,-12.54,;21.03,-13.44,;21.02,-14.98,;19.55,-15.45,;19.07,-16.91,;18.65,-14.2,;19.56,-12.96,;19.08,-11.49,;19.99,-10.25,;19.09,-9,;19.57,-7.53,;21.07,-7.21,;17.62,-9.47,;17.62,-11.01,;16.28,-11.78,;14.95,-11.01,;13.61,-11.77,;14.96,-9.46,;16.29,-8.7,;16.3,-7.15,;17.11,-14.2,;16.33,-15.53,;14.8,-15.53,;14.02,-14.19,;14.8,-12.86,;16.34,-12.87,;12.47,-14.18,;12.47,-15.72,;11.14,-14.94,;11.72,-12.85,)| | ||
| Structure | 
| ||